for Journals by Title or ISSN
for Articles by Keywords
help
Followed Journals
Journal you Follow: 0
 
Sign Up to follow journals, search in your chosen journals and, optionally, receive Email Alerts when new issues of your Followed Jurnals are published.
Already have an account? Sign In to see the journals you follow.
PharmAsia News
   Follow    
   Full-text available via subscription Subscription journal
     ISSN (Print) 1875-7774
     Published by Informa plc Homepage  [13 journals]
  • CBMG To Acquire Agreen In All-China Deal
    • Abstract: In an all-China deal, Cellular Biomedicine Group has agreed to pay $3.3 million in cash plus equity for Agreen Biotech China, which is developing technology and therapies for cancer and immune disorders.
      PubDate: Fri, 15 Aug 2014 02:25:01 -040
       
  • Chikungunya Vaccine In Works
    • Abstract: A vaccine is in development to prevent the mosquito-borne viral disease chikungunya, which has affected nearly two million people in Asia during the past decade.
      PubDate: Fri, 15 Aug 2014 02:10:06 -040
       
  • India Pharm Firms Say Price Controls Dampening Hiring
    • Abstract: Recent Indian regulatory action capping the prices of hundreds of drugs has led to a recruiting slowdown within the pharma industry, in a country experiencing a general hiring surge.
      PubDate: Fri, 15 Aug 2014 02:10:03 -040
       
  • Over 2,000 Shanxi Medical Device Firms Under Investigation
    • Abstract: The Shanxi FDA carried out a broad investigation of the provincial medical device industry in March, dubbed the ‘Five Rectifications’, which included action against of false registration/applications and illegal production.
      PubDate: Fri, 15 Aug 2014 00:10:01 -040
       
  • China To Invest RMB22Bn Into Primary Health Care
    • Abstract: China’s National Development and Reform Commission has disclosed a major investment plan to strengthen the healthcare system down to the primary care level.
      PubDate: Fri, 15 Aug 2014 00:00:10 -040
       
  • NHFPC Sees Success In Domestic Drug Development Effort
    • Abstract: China’s NHFPC sees drug development by domestic pharmaceutical manufacturers as a remarkable achievement.
      PubDate: Thu, 14 Aug 2014 23:45:00 -040
       
  • Baiyunshan’s Generic Viagra Approved For Production
    • Abstract: Guangzhou Baiyunshan Pharmaceutical has announced that its application for generic sildenafil citrate tablets has been updated and now shows as ‘approval completed – card production ordered’ on the website of the China FDA.
      PubDate: Thu, 14 Aug 2014 23:25:00 -040
       
  • No Overall Survival Benefit For Eisai’s Halaven In PhIII NSCLC Trial
    • Abstract: Prolongation of overall survival has not been achieved in an international Phase III trial with Eisai’s Halaven (eribulin mesylate) in the treatment of advanced non-small cell lung cancer.
      PubDate: Thu, 14 Aug 2014 23:15:02 -040
       
  • MSD Japan Set To Launch Orexin Antagonist Sleeping Pill
    • Abstract: MSD will enter the insomnia drug market in Japan with the launch of Belsomra (suvorexant) this fall, which will be the first orexin antagonist to be launched in the country.
      PubDate: Thu, 14 Aug 2014 23:00:00 -040
       
  • Alfresa Launches Metapneumovirus Rapid Diagnostic In Japan
    • Abstract: Alfresa Holdings subsidiary Alfresa Pharma launched Prime Check hMPV, a rapid diagnostic kit for human metapneumovirus in Japan on August 6.
      PubDate: Thu, 14 Aug 2014 22:45:00 -040
       
  • Survey: 80% Have Hard Time Understanding Drug Types
    • Abstract: Up to 80% of Japanese do not understand the differences between OTC drugs and generic drugs for medical use, between various types of OTCs, and between prescription pharmaceuticals and supplements.
      PubDate: Thu, 14 Aug 2014 22:40:00 -040
       
  • Japan Recommends Long-Acting G-CSF Filgrastim
    • Abstract: Japan recommended for approval two pharmaceutical products on August 8, including the new long-acting G-CSF formulation G-Lasta (genetic recombinant pegfilgrastim) from Kyowa Hakko Kirin.
      PubDate: Thu, 14 Aug 2014 22:35:00 -040
       
  • TWi Pharma Launch Of Appetite Generic In U.S. Could Face Delay
    • Abstract: TWi Pharmaceuticals faces a delayed launch of its generic to increase the appetites of anorexia or AIDS patients.
      PubDate: Thu, 14 Aug 2014 18:20:05 -040
       
  • Australia Counts Better Cancer Survival Rates Than New Zealand
    • Abstract: Cancer rates continue to climb in New Zealand more rapidly than in neighboring Australia, according to a study in the New Zealand Medical Journal that covered the years 2000 through 2007.
      PubDate: Thu, 14 Aug 2014 18:20:01 -040
       
  • Aussie Research Identifies Key Gene For Unlimited Stem Cell Creation
    • Abstract: Australian researchers report discovery of a key element that could lead to unlimited laboratory production of embryonic-like stem cells, a published study said.
      PubDate: Thu, 14 Aug 2014 18:10:00 -040
       
  • Vaccines, Biosimilars In Shadow As Sun Shines On Ranbaxy'
    • Abstract: Sun Pharma may eliminate biosimilars and vaccines work that was being done by Ranbaxy at its two units in Hyderabad and Bangalore. The move could symbolize the thinking of Sun management – to stay away from venturing into product segments that are highly competitive or still evolving.
      PubDate: Thu, 14 Aug 2014 17:25:02 -040
       
  • 3SBio Licenses DiNonA's Leukemia Antibody For China
    • Abstract: China's 3SBio is to develop the South Korean firm DiNonA’s leukemia drug leukotuximab in China under a licensing agreement.
      PubDate: Thu, 14 Aug 2014 03:45:02 -040
       
  • Fujifilm and BioCryst Lagging In Ebola Race
    • Abstract: While a few pharma firms are ramping up production of their untested Ebola treatments with the prospect of reaping substantial sales, Fujifilm Holdings’ and BioCryst’s drugs are still at the preclinical stage.
      PubDate: Thu, 14 Aug 2014 03:30:00 -040
       
  • Regulation, Reimbursement Notes From Turkey
    • Abstract: A PharmAsia News update shows Turkey’s Ministry of Health is working on new procedures to ease procurement of unavailable drugs from abroad. As well, Hacettepe University will be producing domestic morphine and vaccine products in Turkey and SGK added 12 drugs to the reimbursement list among other developments.
      PubDate: Thu, 14 Aug 2014 03:15:01 -040
       
  • China Draft Device Naming Rule Bans Brands
    • Abstract: The China FDA has released for public comment a strict new medical device naming regulation that bans the use of brand names or trademarks, requiring instead the use of general ‘generic’ names.
      PubDate: Thu, 14 Aug 2014 03:10:03 -040
       
  • India Mulls Public-Private Funding For Drug Research Institutes
    • Abstract: India's new prime minister is expected to announce government funding for research and development by the drug industry, particularly biotechs, to make the nation a global research player.
      PubDate: Wed, 13 Aug 2014 18:45:05 -040
       
  • Medicines New Zealand Issues New Social Media Rules For Drug Firms
    • Abstract: Medicines New Zealand has imposed new requirements on drug maker members who promote their products on social media.
      PubDate: Wed, 13 Aug 2014 18:35:03 -040
       
  • China's Zai Lab In-Licenses Two Sanofi Respiratory Drugs
    • Abstract: Zai Lab has signed an agreement with Sanofi to in-license two of the France-based company's drugs to develop as treatments for chronic respiratory diseases.
      PubDate: Wed, 13 Aug 2014 18:25:06 -040
       
  • Foreign Firms Eye China Gene Sequencing Business
    • Abstract: Two gene sequencing instrument giants, Illumina and Life Tech, are entering the Chinese market and both are seeking Chinese partners.
      PubDate: Wed, 13 Aug 2014 04:40:02 -040
       
  • Shandong Revises Adverse Events System
    • Abstract: The Shandong FDA has revised its “Emergency Plans for Adverse Events of Drugs and Medical Devices” and classified the adverse events into four categories.
      PubDate: Wed, 13 Aug 2014 04:35:01 -040
       
 
 
JournalTOCs
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Email: journaltocs@hw.ac.uk
Tel: +00 44 (0)131 4513762
Fax: +00 44 (0)131 4513327
 
About JournalTOCs
API
Help
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-2014